rethinkTHC Search
Menu
Study breakdown

How does cannabis-induced psychosis differ from schizophrenia?

Cross SectionalPreliminary evidence
The takeaway

A comparative study of 50 cannabis users with psychosis and 50 schizophrenia patients without cannabis use found distinct symptom profiles, with cannabis psychosis showing more speech-related symptoms and schizophrenia showing more thought disorder.

Clinicians differentiating between cannabis-related and primary psychotic disorders, and readers interested in how cannabis affects brain function differently than schizophrenia.

50 vs 50 patients compared

What the researchers found

Cannabis-using patients with psychosis showed higher scores in pressure of speech, distractible speech, and clanging. Schizophrenia patients without cannabis use showed higher scores in derailment, incoherence, illogicality, and global rating of positive formal thought disorder. Both groups had significantly higher neurological soft sign scores than healthy controls.

Why it matters

Distinguishing cannabis-induced psychosis from schizophrenia has important treatment implications. If the symptom profiles are genuinely different, clinicians may be able to better identify when psychosis is substance-driven versus a primary psychiatric disorder.

The numbers in context

50 cannabis users with psychosis; 50 schizophrenia patients; 30 healthy controls; neurological soft sign scores: CUD with psychosis 20.53, CUD without psychosis 15.93, controls 6.20 (p<0.001)

How the study worked

Cross-sectional hospital-based study comparing 50 cannabis-using patients with psychosis (DSM-5 CUD) to 50 age-matched schizophrenia patients without cannabis use, plus 30 healthy controls. Psychotic symptoms assessed using the Scale for Assessment of Positive Symptoms.

What this study cannot tell us

Relatively small sample from a single hospital. Cross-sectional design cannot determine whether cannabis-induced psychosis represents a distinct disorder or an early manifestation of schizophrenia. Indian population may limit generalizability.

How to read the evidence

Cross-sectional hospital-based study with age-matched comparison groups, but small sample and single-site design.

When this study was published

Published in 2021; ongoing research continues to clarify the relationship between cannabis-induced psychosis and schizophrenia.

The bigger picture

The finding that cannabis-induced psychosis has distinct clinical features supports treating it as a separate diagnostic entity. However, some individuals with cannabis-induced psychosis eventually develop schizophrenia, making the boundary between these conditions less clear-cut than symptom profiles alone might suggest.

Questions still open

  • Do the distinct symptom profiles predict different treatment responses? What proportion of cannabis-induced psychosis cases eventually convert to a primary psychotic disorder? Are these differences related to cannabis dose or duration of use?

Common questions

Is cannabis-induced psychosis the same as schizophrenia?
This study suggests they have different symptom profiles. Cannabis psychosis featured more speech-related symptoms (pressured speech, distractibility), while schizophrenia showed more formal thought disorder (derailment, incoherence).
Can cannabis-induced psychosis become permanent?
This study did not follow patients over time, so it cannot answer this question. Other research suggests a subset of cannabis-induced psychosis cases may progress to chronic psychotic disorders.

Read the original research

Sociodemographic and clinical profile of cannabis-induced psychosis: A comparative study.

Industrial psychiatry journal, 30(Suppl 1), S132-S139

Citation

Padhi, Debasish; Shukla, Priyanka; Chaudhury, Suprakash. (2021). Sociodemographic and clinical profile of cannabis-induced psychosis: A comparative study.. Industrial psychiatry journal, 30(Suppl 1), S132-S139. https://doi.org/10.4103/0972-6748.328804

Explore the wider topic